NEXENTIS TECHNOLOGIES INC. Other Nonrecurring (Income) Expense
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Other Nonrecurring (Income) Expense of -$12.17 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherNonrecurringIncomeExpense · last filed 2024-05-15
- NEXENTIS TECHNOLOGIES INC. other nonrecurring (income) expense for the quarter ending 2024-03-31 was -$12.17K.
- NEXENTIS TECHNOLOGIES INC. other nonrecurring (income) expense for fiscal 2023 was $984.94K.
| Period end | Other Nonrecurring (Income) Expense 3 month | Other Nonrecurring (Income) Expense 12 month |
|---|---|---|
| 2024-03-31 | -$12.17K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $984.94K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |